Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and ...

The first-in-class injectable could be the next big thing in diabetes and obesity treatment.

Researchers in Japan developed an oral insulin pill that lowered blood sugar in diabetic mice, offering hope for a ...

Dr. Reddy’s Laboratories has launched ‘Obeda’, an injectable semaglutide therapy for diabetes and weight management in India.

Type 2 diabetes occurs when the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood sugar levels. Medications aim to lower blood glucose, reduce A1C, and ...

Dr. Reddy's Laboratories has launched Obeda, a generic semaglutide injection for Type 2 diabetes, becoming the first Indian ...

Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and ...